medigraphic.com

2009, Number 1

<< Back Next >>

Rev Med Inst Mex Seguro Soc 2009; 47 (1)

Pellucid Marginal Degeneration and Corneal Ulceration, Associated with Sjögren Syndrome

Fernández-Barboza F, Verdiguel-Sotelo K, Hernández-López A

Language: Spanish
References: 25
Page: 77-82
PDF size: 244.36 Kb.


ABSTRACT

Clinical cases: two cases reported presented corneal topography with peripheral inferior corneal slimming (pachymetry), flattening of superior and central meridian, high stigmatism against the rule, corroborating clinical pellucid marginal degeneration prognosis. A rheumatologist and a dermatologist confirmed primary and secondary Sjögren in each case.
Conclusions: In the cases studied, the pellucid marginal degeneration was presented with inferior corneal slimming, progressive irregular astigmatism and decreased visual acuity. However, the patients were treated for a long time only for dry eye. The association between pellucid marginal degeneration, primary Sjögren syndrome and secondary Sjögren syndrome has not been described. In the analyzed cases, both pathologies were observed and caused a bad prognosis because the treatment required is very difficult.


REFERENCES

  1. Barraquer R, Toledo M, Torres E. Degeneración marginal pelúcida. En: Barraquer RI, De Toledo MC, Torres E, editores. Distrofias y degeneraciones corneales. Atlas y texto. Barcelona, España: Publicaciones Médicas Espaxs; 2004. p. 317-326.

  2. Tzelikis PF, Cohen EJ, Rapuano CJ, Hammersmith KM, Laibson PR. Management of pellucid marginal corneal degeneration. Cornea 2005; 24(5):555-560.

  3. Cheng CL, Theng JT, Tan DT. Compressive Cshaped lamelar keratoplasty: a surgical alternative for the management of severe astigmatism from peripheral corneal degeneration. Ophthalmology 2005;112(3):425-430.

  4. Sridhar MS, Mahesh S, Bansal AK, Nutheti R, Rao GN. Pellucid marginal corneal degeneration. Ophthalmology 2004;111(6):1102-1107.

  5. Javadi MA, Karimian F, Hosseinzadeh A, Noroozizadeh Hm, Sa’eedifar MR, Rabie HM. Lamellar crescentic resection for pellucid marginal corneal degeneration. J Refract Surg 2004; 20(29):162-165.

  6. Sridhar MS, Mahesh S, Bansal AK, Rao GN. Superior pellucid marginal corneal degeneration. Eye 2004;18(4):393-399.

  7. Touriño-Peralba M del R, Rodríguez-Ares MT, De Rojas-Silva V, Pérez-Varela V, Sánchez-Salorio M. Resección lamelar en creciente en la degeneración marginal pelúcida. Arch Soc Esp Oftalmol 1998;7:1-4.

  8. Ambrosio R Jr, Wilson SE. Early pellucid marginal corneal degeneration: case reports of two refractive surgery candidates. Cornea 2002;21(1):114-117.

  9. Ambrosio R Jr, Klyce SD, Wilson SE. Corneal topographic and pachymetric screening of keratorefractive patients. J Refract Surg 2003;19(1):24-29.

  10. Arffa RC. Degeneraciones corneales. En: Arffa RC, editor. Grayson enfermedades de la córnea. Cuarta edición. Madrid, España: Harcourt Brace; 1999. p. 383-412.

  11. Aldave AJ, Mabon M, Hollanger DA, Mcleod SD, Spencer WH, Abbott RL. Spontaneus corneal hydrops and perforation in keratoconus and pellucid marginal degeneration. Cornea 2003;22(2):169-174.

  12. Murube J, Benítez-Del Castillo JM, Chenzhuo L, Berta A, Rolando M. Triple clasificación de Madrid para el ojo seco. Arch Soc Esp Oftalmol 2003; 11:1-7.

  13. Baudouin C. The pathology of dry eye. Surv Ophthalmol 2001;45(Suppl 2):S211-220.

  14. Smith RE. The tear film complex: pathogenesis and emerging therapies for dry eyes. Cornea 2005;24 (1):1-7.

  15. Gulati A, Sacchetti M, Bonini S, Dana R. Chemokine receptor CCR5 expression in conjunctival epithelium of patients with dry eye syndrome. Arch Ophthalmol 2006;124(5):710-716.

  16. Nikitakis NG, Rivera H, Lariccia C, Papadimitriou JC, Sauk JJ. Primary Sjögren syndrome in childhood: report of a case and review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2003;96(1):42-47.

  17. Avunduk AM, Avunduk MC, Varnell ED, Kaufman HE. The comparison of efficacies of topical corticosteroids and nonsteroidal anti-inflammatory drops on dry eye patients: a clinical and immunocytochemical study. Am J Ophthalmol 2003;136(4):593-602.

  18. Fujita M, Igarashi T, Kurai T, Sakane M, Yoshinno S, Takahashi. H. Correlation between dry eye and rheumatoid arthritis activity. Am J Ophthalmol 2005; 140(5):808-813.

  19. Lemp MA. Dry eye (keratoconjunctivitis sicca), rheumatoid arthritis, and Sjögren’s syndrome. Am J Ophthalmol 2005;140(5):898-899.

  20. Wilson DM, John GR, Callen JP, MD. Peripheral ulcerative keratitis-and extracutaneous neutraphilic disorder: report of a patient with rheumatoid arthritis, pustular vasculitis, pyoderma gangrenosum, and Sweet’s syndrome with an excellent response to cyclosporine therapy. J Am Acad Dermatol 1999; 40(2 Pt 2):331-334.

  21. Hellmann D, Stone J, MD. Artritis y trastornos musculoesqueléticos. En: Tierney LM, McPhee SJ, Papadakis MA, editores. Diagnóstico clínico y tratamiento. México: El Manual Moderno; 2001. p. 803-886.

  22. Arnett FC, Edworthy SM, Bloch DA McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987. Revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31(3):315-323.

  23. Tang M, Shekhar R, Miranda D, Huang D. Characteristics of keratoconus and pellucid marginal degeneration in mean curvature maps. Am J Ophthalmol 2005;140(6):993-1001.

  24. Mansour AM, Haddad RS. Corneal topography after ocular rubbing. Cornea 2002;21(8):756-758.

  25. Benítez-del Castillo J, Vico E. Tratamiento del ojo seco. Gac Optica 2004:1-5.




2020     |     www.medigraphic.com